Physician

Gururau Sudarshan, MD, FRCA, FFARCSI

According to 2025 Medicare claims, Gururau Sudarshan, MD, FRCA, FFARCSI (NPI: 1326046871) practices interventional pain management (ipm) in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is CINCINNATI PAIN PHYSICIANS LLC (NPI: 1457790941; TIN: 462969829) and primary practice location at 45249-2279. Sudarshan is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Sudarshan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 208 traditional Medicare patients, billed 6,266 HCPCS/CPT codes, and received $204,473 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,819 prescription claims across 390 beneficiaries totaling $199,856 in drug costs, led by Buprenorphine (Buprenorphine). Open Payments data shows 93 records totaling $4,677. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $268,889 to $199,856. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	421	6,035	$244,433
2016	500	6,313	$313,725
2017	562	8,032	$353,071
2018	596	8,097	$397,888
2019	521	6,888	$351,219
2020	318	4,186	$192,461
2021	265	4,622	$233,014
2022	287	7,415	$274,412
2023	240	4,895	$199,325
2024	208	6,266	$204,473

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	466	2,881	$268,889
2016	523	3,490	$382,272
2017	434	1,679	$134,257
2018	347	1,082	$71,894
2019	429	2,106	$142,864
2020	357	2,390	$117,317
2021	406	1,951	$94,885
2022	373	1,108	$55,822
2023	257	679	$26,835
2024	390	4,819	$199,856

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	651	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	126	343	$54
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	72	612	$0
J1010	Injection, methylprednisolone acetate, 1 mg	47	2,422	$0
J1100	Injection, dexamethasone sodium phosphate, 1 mg	81	1,070	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine	Buprenorphine	153	4,290	$33,887
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	955	28,217	$23,718
Belbuca	Buprenorphine Hcl	34	1,010	$15,642
Oxycontin	Oxycodone Hcl	34	1,019	$15,111
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	514	15,315	$12,063

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$4,677	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gururau Sudarshan, MD, FRCA, FFARCSI?

Tedicare shows public-source Medicare data for Gururau Sudarshan, MD, FRCA, FFARCSI (NPI 1326046871), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gururau Sudarshan, MD, FRCA, FFARCSI have ACO affiliation data?

Gururau Sudarshan, MD, FRCA, FFARCSI is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Gururau Sudarshan, MD, FRCA, FFARCSI?

Gururau Sudarshan, MD, FRCA, FFARCSI is linked to CINCINNATI PAIN PHYSICIANS LLC (billing NPI 1457790941) in the available physician profile data.

Does Gururau Sudarshan, MD, FRCA, FFARCSI have Open Payments data?

Gururau Sudarshan, MD, FRCA, FFARCSI has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.